Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons

  title={Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons},
  author={Torbj{\"o}rn B{\"a}ckstr{\"o}m and David Haage and Magnus L{\"o}fgren and Inga-Maj Johansson and Jessica Str{\"o}mberg and Sigrid Nyberg and Lotta Andr{\'e}en and Lindsey Ossewaarde and Guido A. van Wingen and S. Turkmen and Sara K. S. Bengtsson},

Figures from this paper

Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.

Altered alterations in APS suggest potential GABA-A-R changes across the menstrual cycle and in response to sertraline among treatment responders, suggesting impaired ability to modulate arousal reactivity.

Neurosteroids in the Pathophysiology and Treatment of Mood and Anxiety Disorders

There is evidence that many pharmaceuticals used for mood and anxiety disorders including antidepressants, antipsychotics, and mood stabilizers may be effective secondary to their ability to modulate neurosteroids.

Neurosteroid Influences on Sensitivity to Ethanol

The data suggest that neurosteroids are virtually ubiquitous modulators of inhibitory neurotransmission, possibly related to the efficacy and potency of ethanol to potentiate the release of GABA and increase neurosteroid concentrations.

Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?

Results indicate that inhibiting AP synthesis and signalling reduces the exacerbation of tic severity associated with acute stress, and point to the possibility that the GABAergic activation by AP may also lead to disinhibitory effects, which could interfere with the ability of patients to suppress their tics.

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

Stabilization of allopregnanolone levels from the follicular to the luteal phase of the menstrual cycle by blocking the conversion of progesterone to its 5α-reduced neurosteroid metabolite mitigates symptoms in PMDD provides preliminary support for the pathophysiologic relevance of neurosteroids in this condition.

Multifunctional aspects of allopregnanolone in stress and related disorders

  • Anjana BaliA. Jaggi
  • Biology, Medicine
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2014

Progesterone, reproduction, and psychiatric illness.




The Role of Hormones and Hormonal Treatments in Premenstrual Syndrome

SSRIs and substances inhibiting ovulation, such as gonadotrophin-releasing hormone (GnRH) agonists, have proven to be effective treatments and add-back hormone replacement therapy is recommended to avoid adverse effects when high dosages of GnRH agonists are sed.

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid.

This model reports a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model, and finds that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function.

Progesterone selectively increases amygdala reactivity in women

Investigating whether a single progesterone administration to healthy young women in their follicular phase modulates the amygdala response to salient, biologically relevant stimuli reveals a neural mechanism by which progester one may mediate adverse effects on anxiety and mood.

Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.

The conclusion is that an increase of the estrogen dose accentuates negative mood and physical symptoms during the progestin phase of sequential hormonal therapy.

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

Two metabolites of the steroid hormones progesterone and deoxycorticosterone are potent barbiturate-like ligands of the gamma-aminobutyric acid (GABA) receptor-chloride ion channel complex and potentiated the inhibitory actions of GABA in cultured rat hippocampal and spinal cord neurons, which may explain the ability of certain steroid hormones to rapidly alter neuronal excitability.

Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty.

It is shown that THP (allopregnanolone), a steroid that is released as a result of stress, increases anxiety in pubertal female mice, in contrast to its anxiety-reducing effect in adults.

Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty

It is shown that THP (allopregnanolone), a steroid that is released as a result of stress, increases anxiety in pubertal female mice, in contrast to its anxiety-reducing effect in adults.

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.

In women with premenstrual syndrome, the occurrence of symptoms represents an abnormal response to normal hormonal changes.

Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone

Mood effects during progesterone treatment seem to be related to allopregnanolone concentration, and a bimodal association between allopreginolone and adverse mood is evident.

Persistence of Premenstrual Syndrome During Low-Dose Administration of the Progesterone Antagonist RU 486

Luteal-phase administration of low-dose RU 486 does not significantly reduce the physical or behavioral manifestations of PMS.